AASLD
Conference Coverage
Hepatitis C debrief: Therapy has matured, access issues remain
Hepatitis C virus treatments are now broadly available, but challenges remain in getting the treatments to those who need them.
Conference Coverage
High rates of HCV treatment completion seen in people who inject drugs
Treatment of people who inject drugs will help prevent new cases of HCV, study coauthor maintains.
Conference Coverage
High rates of prescription opioid, benzodiazepine use observed in chronic liver disease
SAN FRANCISCO – Nearly one-quarter were receiving substantial high-dose opioid prescriptions.
Conference Coverage
The Liver Meeting 2016 debrief – key abstracts
BOSTON - Amid a plethora of quality research, several abstracts stood out at the annual meeting of the American Association for the Study of Liver...
Conference Coverage
HCV patients with early-stage hepatocellular carcinoma can achieve SVR
Among patients with hepatocellular carcinoma, rates of sustained viral response to direct-acting regimens for hepatitis C virus were 79% for...
Conference Coverage
Tumor boards linked to improved survival in hepatocellular carcinoma
BOSTON – Veterans were about 13% less likely to die within 5 years of hepatocellular carcinoma diagnosis when multidisciplinary tumor boards...
Conference Coverage
VIDEO: PBC patients with compensated cirrhosis fare well on obeticholic acid
BOSTON - Patients with primary biliary cholangitis who have compensated cirrhosis fared just as well on obeticholic acid as did primary biliary...
Conference Coverage
SNP predicts liver cancer in hepatitis C patients regardless of SVR
BOSTON
Conference Coverage
Treatment withdrawal without prior liver biopsy found safe in well-controlled autoimmune hepatitis
Liver biopsy prior to treatment withdrawal in patients with well-controlled autoimmune hepatitis may be unnecessary, contrary to current...
Conference Coverage
VIDEO: Don’t be surprised by weight gain in men after HCV cure
BOSTON